Skip to main content
Jadranka Dragovic, MD, Radiation Oncology, Detroit, MI

Jadranka Dragovic MD

Radiation Oncology•Detroit, MI

Medical Director/Henry Ford Cottage Radiation Oncology

Join to View Full Profile

  • Henry Ford Health System2799 Wgrand BLVDDetroit, MI 48202

  • Phone+1 313-640-2400

  • Fax+1 313-640-2410

Dr. Dragovic is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Dragovic's Full ProfileAlready have an account?

Summary

  • Dr. Jadranka Dragovic is a radiation oncologist based in Detroit, MI. She completed her medical degree at the University of Belgrade Faculty of Medicine in 1977 and holds a Master's degree in Design, Measurement & Evaluation/Clinical Epidemiology & Biostatics from McMaster University, obtained in 1984. Her publications include reviews and guidelines on topics such as MRI-guided radiotherapy and appropriate use criteria for various cancers, which have been cited numerous times. Dr. Dragovic has received multiple CMS Meaningful Use Stage 1 and Stage 2 Certifications from 2013 to 2017 for various healthcare systems, recognizing her adherence to implementing certain electronic health record and information system requirements.

Education & Training

  • McMaster University
    McMaster UniversityM.S., Design, Measurement & Evaluation/Clinical Epidemiology & Biostatics, 1984
  • University of Belgrade Faculty of Medicine
    University of Belgrade Faculty of MedicineClass of 1977

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1983 - Present
  • MI State Medical License
    MI State Medical License 1985 - 2029
  • Therapeutic Radiology
    American Board of Radiology Therapeutic Radiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2013-2014, 2016-2017

Publications & Presentations

PubMed

Journal Articles

  • ACR appropriateness criteria borderline and unresectable pancrea cancer  
    Small W Jr., Hayes JP, Suh WW, Abdel-Wahab M, Abrams RA, Azad N, Das P, Dragivic J, Goodman K, Jabbour S, Jones W III, Konski A, Koong A, Kumar R, Lee P, Pawlik T, Her..., Oncology, 1/1/2016
  • Molecular characterization of head and neck cancer: how close to personalized therapy?  
    Worsham MJ, Ali H, Dragovic J, Schweitzer VP, Mol Diagn Ther, 1/1/2012
  • Stereotactic body radiation therapy for primary, recurrent and metastatic tumors in the head and neck region  
    Siddiqui F, Patel M, Khan M, McLean S, Dragovic J, Jin JY, Movsas B, Ryu S, IJROBP, 1/1/2009

Books/Book Chapters

  • Oral and Maxilofacial Surgery Clinics of North America 
    Chapter: Nonsurgical management of salivary gland malignancy. The comprehensive management of salivary gland pathology 
    Dragovic JW.B. Saunders Company1995
  • Nutrition in Cancer Prevention and Treatment 
    Chapter: Use of vitamins as adjunct to conventional cancer therapy 
    Kim JH, Kim SH, He SD, Dragovic J, Brown SEditors: Prasad KN.Humana Press, Inc., Totowa, NJ1994
  • Concominant continuous infusion chemotherapy and radiation 
    Chapter: Combined cisplatin and concominant continuous infusion of 5-fluorouracil and accelerated radiation in advanced head and neck cancer 
    Page 239 - 242Dragovic JEditors: Rotman M, Rosenthal C.Springer-Verlag, Berlin & Heidelberg, Germany; New York, N; London, UK; Paris, France; Tokyo, Japan1991

Abstracts/Posters

  • Dosimetric indications for Intensity Modulation Radiation Therapy (IMRT) for the treatment of large right breast volumes
    Robbins J, Alaweih Z, Glide-Hurst C, Siddiqui S, Aldridge K, Dragovic J, Pradhan D, Levin K, Walker E, Proceedings of the ASTRO, Miami, FL, 1/1/2011
  • Late effects and factors predicting long term tumor control insurvivors of accelerated fractionation radiotherapy with concominant chemotherapy for locally advanced un...
    Dragovic J, Doyle TJ, Nichols RD, Jacobsen GR, Proceedings of the 6th International Conference of Radiation Oncology, Melbourne, Australia, 1/1/2001
  • Multidisciplinary approach to cancer care
    Dragovic J, Mercy Health Services Building Lasting Relationships Conference, 1/11/1999

Lectures

  • Potential environmental causes of cancer 
    1/21/2012
  • Palliative radiation therapy - The basics and the future 
    1/4/2010
  • Role of radiaiton therapy in the management of skin cancer and keloids 
    1/12/2009

Other

  • A randomized controlled trial of preoperative chemotherapy and radiotherapy for localized squamous cell carcinoma of the esophagus (Thesis) 
    Dragovic J, McMaster University
    Hamilton, Ontario, Canada - 1/1/1984

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Jadranka Dragovic, Dr. Jadranka Dragovic, MD, Dr. J Dragovic